Heart Failure Pharmacology
Sort by:
Penn Medicine Heart and Vascular Center
Not So Rare Restrictive Cardiomyopathies – Amyloidosis and Sarcoidosis
FEATURING
Erica Zado
- 113 views
- October 17, 2023
The 8th Annual International Hawaii Symposium on Diagnostic and Therapeutic Modalities in Heart Failure
How to Treat Patients with HFpEF
FEATURING
Uri Elkayam
- 42 views
- January 2, 2019
Top Ten Topics in Clinical Cardiology 2023
Panel Discussion #1 on Top Topics in Clinical Cardiology
- 42 views
- November 8, 2023
Canadian Collaborative Research Network
Panel Discussion: HFpEF Treatment, Colchicine, and Lp(a) Levels
- 27 views
- August 13, 2024
Scripps Health
AL Amyloidosis: Making the Diagnosis
FEATURING
Michaela Liedtke
- 148 views
- November 21, 2023
Scripps Health
Best Practices in Managing Cardiac Toxicity in the Cancer Patient: The Cardiologist's Perspective
FEATURING
Margot Davis
- 24 views
- November 21, 2023
Scripps Health
Best Practices in Surveillance and Management of Cardiac Toxicity in the Cancer Patient: the Oncologist's Perspective
FEATURING
Carrie Costantini
- 6 views
- November 21, 2023
Mount Sinai Advanced Heart Symposium 2016
Unexplained Cardiomyopathies: Genes or Viruses
FEATURING
Maria Trivieri
- 23 views
- February 14, 2017
Scripps Health
Current and Emerging Treatments for AL Amyloidosis
FEATURING
Robert Vescio
- 57 views
- November 21, 2023
Scripps Health
Genetic Cardiomyopathies: Who to Screen and What to Look for
FEATURING
Chad Weldy
- 46 views
- November 21, 2023
Scripps Health
Role of Multimodality Imaging in Cardio-Oncology
FEATURING
Purvi Parwani
- 62 views
- November 21, 2023
Scripps Health
Management of End-Stage Heart Failure in the Cancer Survivor
FEATURING
Brian Hardaway
- 13 views
- November 21, 2023
Canadian Collaborative Research Network
REDUCE-AMI Trial – a Post-Lecture Discussion
FEATURING
Narendra Singh,
Milan Gupta
- 6 views
- August 20, 2024
Canadian Collaborative Research Network
REDUCE-AMI – Do Beta-Blockers Impact Outcome Following Acute MI with Preserved EF?
FEATURING
Milan Gupta
- 162 views
- August 20, 2024
AHA 2023 Insights
AHA 2023 Insights: Higher Than Daily RDA Recommended Vitamin D3 Dosing and Multiple Titrations Are Required to Achieve >40 ng/mL 25-hydroxy Vitamin D Levels in Acute Coronary Syndrome Participants Enrolled and Randomized to Targeted Vitamin D Treatment - The Target D Trial
FEATURING
Viet Le
- 141 views
- November 23, 2023
University of Colorado Department of Medicine
CU Cardio-Obstetrics: Our First Year
FEATURING
Josephine Chou
- 37 views
- November 23, 2023